Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.7K
Overview
44.7K
Symbiosis00:58

Symbiosis

28.8K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
28.8K
Cross-reactivity00:42

Cross-reactivity

31.3K
Overview
31.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Cancer Vaccines01:30

Cancer Vaccines

405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Monitoring of Systemic Cytokines After Mild Zika Virus Infection Revealed an Association Between Th17 Polarization and Clinical and Serological Outcomes.

Journal of medical virology·2026
Same author

IFN-γ and IL-4 correlate with protection induced by an attenuated malaria vaccine.

NPJ vaccines·2025
Same author

Lessons for medical countermeasure development from unforeseen outbreaks.

Emerging microbes & infections·2025
Same author

Induction of tissue resident memory T cells by measles vaccine vector.

Human vaccines & immunotherapeutics·2024
Same author

Applying Reverse Genetics to Study Measles Virus Interactions with the Host.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights.

Journal of travel medicine·2023

Related Experiment Video

Updated: Jul 20, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K

[Vaccination against malaria].

Marie Mura1,2

  • 1Unité Immunopathologie, Département Microbiologie et maladies infectieuses, Institut de recherche biomédicale des armées (IRBA), 1 place du Général Valérie André, 91220 Brétigny-sur-Orge, France.

Medecine Tropicale Et Sante Internationale
|August 1, 2023
PubMed
Summary

The first malaria vaccine, RTS,S/AS01, is recommended by the WHO for children in high-transmission areas. Ongoing research aims to improve malaria control with new vaccine strategies.

Keywords:
Alphonse LaveranMalariaPlasmodium falciparumPreventionRTS,S/AS01Sub-Saharan AfricaVaccinationWHO

More Related Videos

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

6.5K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.4K

Related Experiment Videos

Last Updated: Jul 20, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K
Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

6.5K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.4K

Area of Science:

  • Vaccinology
  • Parasitology
  • Infectious Diseases

Context:

  • Malaria remains a significant global health challenge, particularly in sub-Saharan Africa.
  • The development of an effective malaria vaccine has been a long-standing goal.
  • Recent advancements have led to the recommendation of the first malaria vaccine, RTS,S/AS01.

Purpose:

  • To review the progress and limitations of various malaria vaccine candidates.
  • To discuss the RTS,S/AS01 vaccine's development and deployment.
  • To explore future directions in malaria vaccine research.

Summary:

  • The RTS,S/AS01 vaccine, targeting Plasmodium falciparum, received a positive opinion from the European Medicines Agency in 2015.
  • Following successful pilot programs, the World Health Organization now recommends its widespread use in children over 5 months old in endemic regions.
  • The article examines different vaccine strategies targeting various parasite stages and discusses ongoing research into correlates of protection.

Impact:

  • The RTS,S/AS01 vaccine represents a milestone in malaria control efforts.
  • WHO recommendations facilitate the deployment of this vaccine in conjunction with other preventive measures.
  • Advances in vaccine platforms may lead to next-generation vaccines offering broader protection against malaria.